6Gisbert JP, Gomollon F,Mate J, et al. Role of 5 aminosalicylic acid in treatment of inflammatory bowel disease: a systematic renew. Dig DisSci, 2002, 47 (3) : 4712488. 被引量：1
7Schroder KW. Role of mesalazine in acute and long- term treatment of ulcerative colitis and its complications. Stand J Gas, 2002, 236Suppl: 42- 47. 被引量：1
8Fabia R,Ar Raj/lb A, JohanssonML, et al. Impairment of bacterial florze in human ulcerative colitis and experimental colitis in the rat. Digestion, 2003, 54 (4) : 2482255. 被引量：1
1Ardizzone S, Doldo P, Ranzi T, et al. Mesalazine foam(salofalk foam)in the treatment of active distal ulcerative colitis:acomparative trial vs Salofalk enema. Ital J Gastroenterol Hepatol, 1999, 31 (8) : 677-684. 被引量：1
2Schroeder KW. Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications. Scand J Gas, 2002,236Suppl: 42-47. 被引量：1
3Fernandez J, Sala M, Panes J, et al. Acute pancreatitis after long-term 5-aminosalicylic acid therapy. Am J Gastroenterol, 1997,92 (12):2302-2303. 被引量：1
4Gisbert JP,Gomollon F, Mate J,et al. Role of 5-aminosalicylic acid in treatment of inflamematory bowel disease :a systematic review. Dig Dis Sci,2002,47(3):471-488. 被引量：1
2Vegter S,Tolley K,Wilson Waterworth T,et al.Meta-analysis using individual patient data:efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitis[J].Aliment Pharmacol Ther,2013,38(3):284-293. 被引量：1
3Mardini HE, Grigorian AY. Probiotic mix VSL#3 is effectiveadjunctive therapy for mild to moderately active ulcerative colitis: ameta-analysis[J]. Inflammatory bowel diseases, 2014, 20(9):1562-1567. 被引量：1
4Jonkers D, Penders J, Masclee A, et al. Probiotics in the managementof inflammatory bowel disease: a systematic review of interventionstudies in adult patients[J]. Drugs, 2012, 72(6): 803-823. 被引量：1
6Shah SB. Probiotics for ulcerative colitis. Are the good bugsback?[J]. Gastroenterology, 2010, 139(3): 1054-1056; discussion 6. 被引量：1
7Veerappan GR, Betteridge J, Young PE. Probiotics for the treatmentof inflammatory bowel disease[J]. Curr Gastroenterol Rep, 2012,14(4): 324-333. 被引量：1
8Vanderpool C, Yan F, Polk DB. Mechanisms of probiotic action:Implications for therapeutic applications in inflammatory boweldiseases[J]. Inflammatory Bowel Diseases, 2008, 14(11): 1585-1596. 被引量：1
